| Sign In to gain access to subscriptions and/or personal tools. |
Blepharoptosis Following Oxaliplatin Administration
City of Hope National Medical Center
* To whom correspondence should be addressed. E-mail: clau{at}coh.org.
Oxaliplatin is a unique platinum derivative with anti-tumor activity in a number of malignancies, with neurotoxicity being a frequent side effect. Neurotoxicity can manifest in an acute phase and a chronic phase. The acute phase usually presents as dysesthesias of the hands and feet, jaw tightness, and pharyngolaryngo-dysesthesia, triggered and exacerbated by physical contact with cold temperatures. Although various other symptoms have been reported in the literature, little details are available. We report here, in detail, a case of blepharoptosis which appeared after repeated oxaliplatin infusions, and the disappearance of which seemed to be dependent on the infusion rate.
First published on April 28, 2009 |
||||||
 |
|
|
 |
Sign In to gain access to subscriptions and/or personal tools.
